(Q36223556)

12 August 2017

title

History of evidence-based medicine. Oranges, chloride of lime and leeches: barriers to teaching old dogs new tricks (English)

1 reference

12 August 2017

main subject

evidence-based medicine

1 reference

Steven Doherty

1

1 reference

12 August 2017

publication date

1 August 2005

1 reference

Emergency Medicine Australasia

12 August 2017

published in

1 reference

12 August 2017

volume

17

1 reference

12 August 2017

issue

4

1 reference

12 August 2017

page(s)

314-321

1 reference

Central Challenges Facing the National Clinical Research Enterprise

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-6723.2005.00752.X

Controlled trials: the 1948 watershed

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-6723.2005.00752.X

The principles of evidence-based medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-6723.2005.00752.X

Smoking prevalence in neighborhood and hospital controls: implications for hospital-based case-control studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-6723.2005.00752.X

The quality of health care delivered to adults in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-6723.2005.00752.X

From best evidence to best practice: effective implementation of change in patients' care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-6723.2005.00752.X

Why don't physicians follow clinical practice guidelines? A framework for improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-6723.2005.00752.X

Why do doctors use treatments that do not work?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-6723.2005.00752.X

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-6723.2005.00752.X

A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-6723.2005.00752.X

Efficacy and safety of recombinant human activated protein C for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-6723.2005.00752.X

Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-6723.2005.00752.X

Risks and benefits of activated protein C treatment for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-6723.2005.00752.X

Recombinant human activated protein C in sepsis: inconsistent trial results, an unclear mechanism of action, and safety concerns resulted in labeling restrictions and the need for phase IV trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-6723.2005.00752.X

Evidence based medicine: Socratic dissent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-6723.2005.00752.X

10.1111/J.1742-6723.2005.00752.X

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference